Influence of Diabetes Mellitus on Outcomes in Patients After Left Ventricular Assist Device Implantation

被引:18
|
作者
Usoh, Chinenye O.
Sherazi, Saadia
Szepietowska, Barbara
Kutyifa, Valentina
McNitt, Scott
Papernov, Anna
Wang, Meng
Alexis, Jeffrey D.
机构
[1] Wake Forest Univ, Sch Med, Div Endocrinol & Metab, Winston Salem, NC 27109 USA
[2] Univ Rochester, Med Ctr, Heart Res Follow Up Program, Cardiol Div, Rochester, NY 14642 USA
[3] Univ Rochester, Sch Med & Dent, Div Cardiol, Rochester, NY USA
来源
ANNALS OF THORACIC SURGERY | 2018年 / 106卷 / 02期
关键词
ADVANCED HEART-FAILURE; RISK-FACTORS; STROKE; IMPACT; IMPROVEMENT; PREVALENCE; PLACEMENT;
D O I
10.1016/j.athoracsur.2018.02.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Despite previous studies, the mortality risk of patients with diabetes mellitus after left ventricular assist device (LVAD) implant remains unclear. In addition, the relationship between the degree of glycemic control and long-term mortality risk in LVAD patients with diabetes has not been established. Methods. Ninety-five nondiabetic patients and 96 diabetic patients from the University of Rochester Medical Center who received a HeartMate II (Thoratec, Pleasanton, CA) continuous-flow LVAD between May 2008 and June 2014 were included in this study. The primary outcome was all-cause mortality. Secondary outcomes included rates of infection, neurologic dysfunction, renal dysfunction, and rehospitalization. Kaplan-Meier survival analyses and Cox models were utilized. Results. During follow-up, 32 diabetic patients (33%) and 15 nondiabetic patients (16%) died after LVAD implantation. Cumulative probability of death was higher for diabetic patients when compared with nondiabetic patients (42% versus 21% at 3 years, p = 0.013). There were no significant differences in overall rates of infection, neurologic dysfunction, and rehospitalization between the two groups. However, after an initial secondary outcome event, diabetic patients continued to have a higher mortality rate when compared with nondiabetic patients. There was no statistically significant difference in the risk of death between diabetic patients with pre-LVAD hemoglobin A1c less than 7.0% and diabetic patients with pre-LVAD hemoglobin A1c 7.0% or greater (hazard ratio 1.71, 95% confidence interval: 0.72 to 4.08, p = 0.223). Conclusions. Diabetic patients who underwent LVAD implantation had a higher risk of death compared with nondiabetic patients. Adverse event rates did not differ between the two groups. Finally, the degree of glycemic control in diabetic patients before LVAD was not found to influence mortality. (C) 2018 by The Society of Thoracic Surgeons
引用
收藏
页码:555 / 560
页数:6
相关论文
共 50 条
  • [21] Effects of Diabetes Mellitus on Clinical Outcomes After Left Ventricular Assist Device Implantation: A Single Institutional 9-Year Experience
    Asleh, R.
    Schettle, S. D.
    Briasoulis, A.
    Tchantchaleishvili, V.
    Pereira, N.
    Edwards, B.
    Clavell, A. L.
    Maltais, S.
    Joyce, D. L.
    Park, S. J.
    Joyce, L. D.
    Daly, R.
    Kushwaha, S.
    Stulak, J. M.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S42 - S42
  • [22] Impact of Diabetes Mellitus on Outcomes in Patients with Left Ventricular Assist Devices
    Crugnola, William
    Cinquina, Andrew
    Mattimore, Daniel
    Bitzas, Savannah
    Schwartz, Jonathon
    Zaidi, Saleem
    Bergese, Sergio D.
    BIOMEDICINES, 2024, 12 (07)
  • [23] Ventricular arrhythmias after left ventricular assist device implantation
    Refaat, Marwan
    Chemaly, Elie
    Lebeche, Djamel
    Gwathmey, Judith K.
    Hajjar, Roger J.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2008, 31 (10): : 1246 - 1252
  • [24] Frailty and outcomes after implantation of left ventricular assist device as destination therapy
    Dunlay, Shannon M.
    Park, Soon J.
    Joyce, Lyle D.
    Daly, Richard C.
    Stulak, John M.
    McNallan, Sheila M.
    Roger, Veronique L.
    Kushwaha, Sudhir S.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : 359 - 365
  • [25] Clinical Predictors and Outcomes After Left Ventricular Assist Device Implantation and Tracheostomy
    Lamba, Harveen K.
    Hart, Lucy D.
    Zhang, Qianzi
    Loera, Jackquelin M.
    Civitello, Andrew B.
    Nair, Ajith P.
    Senussi, Mourad H.
    Loor, Gabriel
    Liao, Kenneth K.
    Shafii, Alexis E.
    Chatterjee, Subhasis
    TEXAS HEART INSTITUTE JOURNAL, 2023, 50 (04)
  • [26] Effect of tobacco smoking on outcomes after left ventricular assist device implantation
    Combs, Pamela
    Imamura, Teruhiko
    Siddiqi, Umar
    Spiller, Robert E.
    Williamson, Rebecca
    Mirzai, Saeid
    Symalla, Trevor
    LaBuhn, Colleen
    Jeevanandam, Valluvan
    ARTIFICIAL ORGANS, 2020, 44 (07) : 693 - 699
  • [27] Impact of hepatic steatosis on outcomes after left ventricular assist device implantation
    Hong, Yeahwa
    Dufendach, Keith
    Wang, Yisi
    Thoma, Floyd
    Kilic, Arman
    JOURNAL OF CARDIAC SURGERY, 2021, 36 (07) : 2277 - 2283
  • [28] Optimization with levosimendan improves outcomes after left ventricular assist device implantation
    Kocabeyoglu, Sinan Sabit
    Kervan, Umit
    Sert, Dogan Emre
    Karahan, Mehmet
    Aygun, Emre
    Beyazal, Osman Fehmi
    Unal, Ertekin Utku
    Akin, Yesim
    Demirkan, Burcu
    Pac, Mustafa
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 57 (01) : 176 - 182
  • [29] The impact of extreme obesity on outcomes after left ventricular assist device implantation
    Yost, Gardner
    Coyle, Laura
    Gallagher, Colleen
    Graney, Nicole
    Siemeck, Roxanne
    Tatooles, Antone
    Pappas, Patroklos
    Bhat, Geetha
    JOURNAL OF THORACIC DISEASE, 2017, 9 (11) : 4441 - 4446
  • [30] Caregiver status and outcomes after durable left ventricular assist device implantation
    Koeckert, Michael
    Vining, Patrick
    Reyentovich, Alex
    Katz, Stuart D.
    DeAnda, Abe, Jr.
    Philipson, Stefanie
    Balsam, Leora B.
    HEART & LUNG, 2017, 46 (02): : 74 - 78